全球迷幻药市场 – 行业趋势及 2031 年预测

Customize Your Report Customize Your Report 立即购买 立即购买 免费样本报告 免费样本报告
Home Pharmaceutical Global Psychedelic Drugs Market
请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球迷幻药市场 – 行业趋势及 2031 年预测

  • Pharmaceutical
  • Upcoming Report
  • Apr 2024
  • Global
  • 350 页面
  • 桌子數： 220
  • 图号： 60
立即购买 立即购买

Global Psychedelic Drugs Market

市场规模（十亿美元）

CAGR :  % Diagram

Diagram Forecast Period
 2024 –2031
Diagram Market Size (Base Year)
 USD 2.71 Billion
Diagram Market Size (Forecast Year)
 USD 7.35 Billion
Diagram CAGR
 %
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5
Request For Unlock

>全球迷幻药市场，按来源（合成和天然）、类型（致幻剂、解离剂等）、药物（γ-羟基丁酸、氯胺酮、裸盖菇素、麦角酸二乙酰胺 (LSD)、3,4-甲基苯丙胺等）、应用（发作性睡病、难治性抑郁症、重度抑郁症、阿片类药物成瘾、创伤后应激障碍等）、给药途径（口服、吸入和注射）、最终用户（医院、专科诊所、家庭护理等）、分销渠道（医院药房、零售药房和网上药房）划分 - 行业趋势和预测到 2031 年。

迷幻药市场

迷幻药市场分析及规模

迷幻药市场包括一系列被归类为共情剂、解离剂和其他物质的物质。MDMA 等共情剂可以增强同理心和社交能力，而氯胺酮等解离剂可以产生脱离现实的感觉。其他迷幻药，如裸盖菇素蘑菇和 LSD，可以改变感知和认知。

2023 年全球迷幻药市场规模价值 27.1 亿美元，预计到 2031 年将达到 73.5 亿美元，2024 年至 2031 年预测期内的复合年增长率为 13.3%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

报告范围和市场细分       

报告指标

细节

预测期

2024 至 2031 年

基准年

2023

历史岁月

2022 (可定制为 2016-2021)

定量单位

收入（单位：十亿美元）、销量（单位：台）、定价（美元）

涵盖的领域

来源（合成和天然）、类型（共情剂、解离剂等）、药物（γ-羟基丁酸、氯胺酮、裸盖菇素、麦角酸二乙酰胺 (LSD)、3,4-甲基苯丙胺等）、用途（发作性睡病、难治性抑郁症、重度抑郁症、阿片类药物成瘾、创伤后应激障碍等）、给药途径（口服、吸入和注射）、最终用户（医院、专科诊所、家庭护理等）、分销渠道（医院药房、零售药房和网上药房）

覆盖国家

美国、加拿大、墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲其他地区、巴西、阿根廷和南美洲其他地区

涵盖的市场参与者

Jazz Pharmaceuticals, Inc.（美国）、Janssen Pharmaceuticals, Inc.（美国）、Hikma Pharmaceuticals PLC（英国）、Compass（美国）、Verrian（德国）、Pfizer Inc.（美国）、F. Hoffmann-La Roche Ltd（瑞士）、Avadel（爱尔兰）、Celon Pharma SA（波兰）、Cybin Corp.（加拿大）、GH Research（爱尔兰）、Entheon Biomedical Corp（加拿大）、PharmaTher Holdings Ltd.（印度）、NRx Pharmaceuticals, Inc.（美国）和 Usona Institute（美国）

市场机会
  • 增加研究经费
  •  产学研合作

市场定义

迷幻药是一种能够引起感知、情绪和认知变化的物质，通常会带来强烈的主观体验。这些化合物的例子包括裸盖菇素（存在于某些蘑菇中）、LSD 和 MDMA。它们主要针对大脑中的血清素受体，目前正在研究其在治疗精神健康障碍方面的潜在治疗益处，尤其是在有监督的情况下使用时。                    

迷幻药市场动态

驱动程序

  • 迷幻疗法支持率上升

医疗保健行业越来越多地接受迷幻疗法，因为许多临床试验证明了裸盖菇素和 MDMA 等物质对抑郁症、创伤后应激障碍和成瘾等疾病的治疗前景。医疗保健专业人士和监管机构的这种不断变化的态度正在促进迷幻辅助疗法更广泛地纳入传统医疗保健方法，从而推动市场大幅扩张。

  • 全球范围内转向迷幻药合法化和非刑事化 

世界各国政府正在重新评估迷幻药政策，承认其在治疗精神疾病方面的治疗潜力。这一转变包括将持有迷幻药合法化，甚至将医疗和娱乐用途合法化。这些政策变化为市场研究、开发和商业化创造了新的机会，并推动了市场的增长。

机会

  • 产学研合作

学术机构贡献科学研究和专业知识，而行业合作伙伴则为药物开发、配方和商业化提供资源和见解。这种合作加速了科学发现转化为创新疗法，在市场需求不断增长的情况下为两个行业提供了有利可图的机会。

  • 增加研究经费

不断增加的研究资金促进了对迷幻化合物的治疗应用、安全性和作用机制的广泛科学研究。这种资金支持促进了新型候选药物的发现并增强了现有的治疗方法，吸引了公共和私人投资并推动了市场的增长和扩张。

限制/挑战

  • 文化障碍

在保守价值观占主导地位的地区，或者迷幻药的使用与文化规范或宗教信仰相抵触的地区，人们对这些物质的接受度可能会受到限制。这种接受度的缺乏可能会导致对迷幻疗法的需求减少，医护人员开具迷幻药的意愿下降，以及监管审批流程的困难，这可能会给市场带来挑战。 

  • 滥用和公共安全问题

滥用，无论是娱乐性使用还是未经医疗监督自行使用，都可能导致不良影响，如心理困扰或潜在精神健康状况恶化。这些事件引起了监管机构、医疗专业人士和公众的怀疑，扰乱了迷幻疗法的广泛接受。

本迷幻药市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响，分析了新兴收入来源、市场法规变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新等方面的机会。如需了解有关迷幻药市场的更多信息，请联系 Data Bridge Market Research 获取分析师简报，我们的团队将帮助您做出明智的市场决策，实现市场增长。

最新动态

  • 2023 年 9 月，Cybin Inc. 宣布与知名迷幻疗法继续教育提供商 Fluence 建立战略合作伙伴关系。此次合作旨在加强 EMBARK 培训计划在 CYB003 第 3 阶段试验中的扩展
  • 2022 年 10 月，领先的心理健康护理公司 Numinus Wellness Inc. 推出了一项开创性计划，提供氯胺酮用于治疗慢性和严重的疾病。最初，这项开创性的计划是在犹他州、不列颠哥伦比亚省和魁北克省的 Numinus 诊所推出的

迷幻药市场范围

迷幻药市场根据来源、类型、药物、应用、给药途径、最终用户和分销渠道进行细分。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。

来源

  • 合成的
  • 自然的

类型

  • 共情因素
  • 解离性药物
  • 其他的

药物

  • γ-羟基丁酸
  • 氯胺酮
  • 裸盖菇素
  • 麦角酸二乙酰胺 (LSD)
  •  3,4-亚甲基二氧基甲基苯丙胺
  • 其他的

应用

  • 嗜睡症
  • 难治性抑郁症
  • 重度抑郁症
  • 鸦片成瘾
  • 创伤后应激障碍
  • 其他的

 给药途径

  • 口服
  • 吸入
  • 注射剂

终端用户

  • 医院
  • 专科诊所
  • 家庭护理
  • 其他的

 分销渠道

  • 医院药房
  • 零售药店
  • 网上药店

迷幻药市场区域分析/见解

对迷幻药 市场进行了分析，并按国家、来源、类型、药物、应用、给药途径、最终用户和分销渠道提供了市场规模洞察和趋势。

市场覆盖的国家包括美国、加拿大、墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲其他地区、巴西、阿根廷和南美洲其他地区。

由于北美地区精神疾病患病率高，预计该地区将占据市场主导地位，持续的研发工作推动了市场增长。这种持续的领导地位凸显了北美在影响全球迷幻药市场方向方面的关键作用。

由于医疗保健基础设施不断扩大和公众意识不断增强，预计亚太地区将在预测期内实现显著增长。随着该地区对心理健康服务和教育的投资，以及对迷幻疗法的接受度不断提高，该地区正成为市场全球扩张和发展的关键贡献者。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

医疗保健基础设施增长安装基础和新技术渗透

迷幻药市场还为您提供每个国家/地区资本设备医疗保健支出增长、迷幻药市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗保健监管情景的变化及其对迷幻药市场的影响的详细市场分析。数据适用于 2016-2021 年的历史时期。

竞争格局和迷幻药市场份额分析

迷幻药市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对市场的关注有关。

市场上的一些主要参与者包括：

  • Jazz Pharmaceuticals, Inc.（美国），
  • 杨森制药公司（美国）
  • Hikma Pharmaceuticals PLC（英国）
  • 指南针（美国）
  • 韦里安（德国）
  • 辉瑞公司 (美国)
  • F. Hoffmann-La Roche Ltd（瑞士）
  • Avadel（爱尔兰）
  • Celon Pharma SA.（波兰）
  • Cybin Corp.（加拿大）
  • GH 研究（爱尔兰）
  • Entheon Biomedical Corp（加拿大）
  • PharmaTher Holdings Ltd. (印度)
  • NRx Pharmaceuticals, Inc.（美国）
  • Usona 研究所（美国）表格顶部

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

Sample Image Click on image to enlarge
  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of GLOBAL Psychedelic drugs MARKET
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. type of Psychedelic drugs LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. MARKET APPLICATION COVERAGE GRID
    11. vendor share analysis
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. premium insight
  5. epidemiology
  6. REGULATORY FRAMEWORK: GLOBAL PSYCHEDELIC DRUGS MARKET
    1. REGULATORY SCENARIO IN INDIA
    2. REGULATORY SCENARIO IN UAE
    3. REGULATORY SCENARIO IN AFRICA
    4. REGULATORY SCENARIO IN THE U.S.
    5. REGULATORY SCENARIO IN BRAZIL
    6. REGULATORY SCENARIO IN THE U.K.
  7. Pipeline analysis
  8. market overview
    1. DRIVERS
      1. GROWING ACCEPTANCE OF PSYCHEDELIC DRUGS FOR TREATING DEPRESSION
      2. INCREASING PREVALENCE OF DEPRESSION AND MENTAL DISORDERS
      3. RISING AWARENESS TOWARDS MENTAL HEALTH
      4. ONGOING CLINICAL TRIALS
      5. RISE IN PRODUCT APPROVALS
    2. RESTRAINTS
      1. STRINGENT REGULATIONS FOR PSYCHEDELIC DRUGS
      2. HIGH COST OF PSYCHEDELIC DRUGS
      3. PATENT EXPIRY OF PSYCHEDELIC DRUGS
    3. OPPORTUNITIES
      1. INCREASING R&D ACTIVITIES IN PSYCHEDELIC DRUGS
      2. BREAKTHROUGH THERAPY DESIGNATION BY REGULATORY AUTHORITY
      3. UPCOMING REHABILITATION CENTERS
      4. AVAILABILITY OF CERTIFIED HEALTHCARE PROFESSIONALS
    4. CHALLENGES
      1. SIDE EFFECTS ASSOCIATED WITH PSYCHEDELIC DRUGS
      2. RISE IN ALTERNATIVES
      3. OTHER TREATMENT OPTIONS
  9. COVID-19 IMPACT ON GLOBAL PSYCHEDELIC DRUGS MARKET
    1. IMPACT ON PRICE
    2. IMPACT ON DEMAND
    3. IMPACT ON SUPPLY CHAIN
    4. STRATEGIC DECISIONS FOR MANUFACTURERS
    5. CONCLUSION
  10. global psychedelic drug market, BY source
    1. overview
    2. SYNTHETIC
    3. natural
  11. global psychedelic drugs MARKET, BY type
    1. overview
    2. empathogens
    3. dissociatives
    4. others
  12. global psychedelic drugs MARKET, BY drugs
    1. overview
    2. gamma-hydroxybutyric acid
    3. ketamine
    4. psilocybin
    5. others
  13. global psychedelic drugs MARKET, BY appplication
    1. overview
    2. narcolepsy
    3. Treatment resistant depression
    4. major depressive disorder
    5. opiate addiction
    6. post-traumatic stress disorder
    7. others
  14. global psychedelic drug market, BY route of administration
    1. overview
    2. oral
    3. inhalation
    4. injectable
  15. global psychedelic drugs MARKET, BY end user
    1. overview
    2. hospitals
    3. Specialty Clinics
    4. Homecare
    5. others
  16. global psychedelic drugs MARKET, BY distribution channel
    1. overview
    2. Hospital Pharmacy
    3. retail Pharmacy
    4. online Pharmacy
  17. GLOBAL Psychedelic Drugs MARKET, BY region
    1. Overview
    2. NORTH AMERICA
      1. u.s.
      2. canada
      3. mexico
    3. EUROPE
      1. Germany
      2. U.K.
      3. France
      4. Italy
      5. SPAIN
      6. Russia
      7. Poland
      8. Switzerland
      9. Netherlands
      10. Hungary
      11. Austria
      12. Norway
      13. Ireland
      14. Belgium
      15. Lithuania
      16. rest of europe
    4. middle east & africa
      1. Saudi Arabia
      2. israel
      3. EGYPT
      4. uae
  18. Global Psychedelic drugs market: COMPANY landscape
    1. company share analysis: global
    2. company share analysis: north america
    3. company share analysis: europe
    4. company share analysis: Middle East AND Africa
  19. swot
  20. company profile
    1. JAZZ PHARMACEUTICALS, INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    2. JANSSEN PHARMACEUTICALS, INC. (A SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    3. Pfizer Inc.
      1. REVENUE ANALYSIS
      2. company share analysis
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    4. VERRIAN
      1. COMPANY SNAPSHOT
      2. company share analysis
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    5. AVADEL
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. RECENT DEVELOPMENTS
    6. Celon Pharma S.A.
      1. COMPANY SNAPSHOT
      2. PIPELINE PORTFOLIO
      3. RECENT DEVELOPMENTS
    7. COMPASS
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    8. F. Hoffmann-La Roche Ltd
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    9. HIKMA PHARMACEUTICALS PLC
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    10. neuroRX, Inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    11. PHARMATHER INC.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    12. usonainstitute.org
      1. INSTITUTE SNAPSHOT
      2. PIPELINE PORTFOLIO
      3. RECENT DEVELOPMENTS
  21. questionnaire
  22. related reports

表格列表

TABLE 1 U.S. psychedelic drugs market, company wise pipeline analysis

TABLE 2 U.S. psychedelic drugs market, Research Institute pipeline analysis

TABLE 3 Psychedelics researches, in Europe

TABLE 4 Mental Illness in the U.S. adults, in 2018

TABLE 5 Mental Disorders, in the U.S. adults, in 2018

TABLE 6 More than one in six people in EU countries have a mental health problem

TABLE 7 Men are more likely to die from suicide, in all EU countries

TABLE 8 Mental Disorders causeD by usage of substance disorders, in world, in 2017

TABLE 9 Drug Development Pathway for FDA approval of New Medications

TABLE 10 The 1971 UN Convention on Psychotropic Substances

TABLE 11 cost of psychedelic drugs

TABLE 12 Total costs (direct and indirect) of mental health problems in EU countries, in million and as a share of GDP, In 2015

TABLE 13 psychedelic drugs R&D activities

TABLE 14 Global Psychedelic drug market, By source 2020-2028 (USD Million)

TABLE 15 Global Synthetic in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 16 Global Natural in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 17 global psychedelic drug market, By Type, 2020-2028 (USD Million)

TABLE 18 Global Empathogens in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 19 Global Dissociatives in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 20 Global Others in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 21 Global Therapy in Psychedelic Drugs Market, By Drugs, 2019-2028 (USD Million)

TABLE 22 Global Gamma-Hydroxybutyric Acid in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 23 Global Ketamine in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 24 Global Psilocybin in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 25 Global Others in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 26 Global application in psychedelic drugs Market, By Application, 2019-2028 (USD Million)

TABLE 27 Global Narcolepsy in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 28 Global Treatment Resistant Depression in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 29 Global Major Depressive Disorder in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 30 Global Opiate Addiction in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 31 Global Post-Traumatic Stress Disorder in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 32 Global Others in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 33 Global Psychedelic Drugs Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 34 Global Oral in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 35 Global Inhalation in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 36 Global Injectable in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 37 global psychedelic drug market, By END USER, 2020-2028 (USD Million)

TABLE 38 Global Hospitals in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 39 Global Specialty Clinics in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 40 Global Homecare in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 41 Global Others in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 42 global medication & supplements in psychedelic drug market, By distribution channel, 2020-2028 (USD million)

TABLE 43 Global Hopitals Pharmacy in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 44 Global Retail Pharmacy in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 45 Global Online Pharmacy in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 46 GLOBAL Psychedelic Drugs MARKET, By Region, 2018-2027 (USD million)

TABLE 47 NORTH AMERICA PSYCHEDELIC DRUGS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 48 NORTH AMERICA PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 49 NORTH AMERICA PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 50 NORTH AMERICA PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 51 NORTH AMERICA PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 52 NORTH AMERICA PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 53 NORTH AMERICA PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 54 NORTH AMERICA PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 55 u.s.PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 56 u.s. PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 57 u.s. PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 58 u.s. PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 59 u.s. PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 60 u.s. PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 61 u.s. PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 62 canada PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 63 canada PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 64 canada PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 65 canada PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 66 canada PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 67 canada PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 68 canada PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 69 mexico PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 70 mexico PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 71 mexico PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 72 mexico PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 73 mexico PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 74 mexico PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 75 mexico PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 76 EUROPE PSYCHEDELIC DRUGS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 77 EUROPE PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 78 EUROPE PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 79 EUROPE PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 80 EUROPE PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 81 EUROPE PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 82 EUROPE PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 83 EUROPE PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 84 Germany PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 85 Germany PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 86 Germany PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 87 Germany PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 88 Germany PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 89 Germany PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 90 Germany PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 91 U.K. PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 92 U.K. PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 93 U.K. PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 94 U.K. PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 95 U.K. PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 96 U.K. PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 97 U.K. PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 98 France PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 99 France PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 100 France PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 101 France PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 102 France PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 103 France PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 104 France PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 105 Italy PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 106 Italy PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 107 Italy PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 108 Italy PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 109 Italy PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 110 Italy PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 111 Italy PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 112 spain PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 113 Spain PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 114 Spain PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 115 Spain PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 116 Spain PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 117 Spain PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 118 Spain PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 119 RUSSIA PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 120 Russia PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 121 Russia PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 122 Russia PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 123 Russia PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 124 Russia PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 125 Russia PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 126 Poland PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 127 Poland PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 128 Poland PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 129 Poland PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 130 Poland PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 131 Poland PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 132 Poland PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 133 Switzerland PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 134 Switzerland PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 135 Switzerland PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 136 Switzerland PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 137 Switzerland PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 138 Switzerland PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 139 Switzerland PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 140 Netherlands PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 141 Netherlands PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 142 Netherlands PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 143 Netherlands PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 144 Netherlands PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 145 Netherlands PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 146 Netherlands PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 147 Hungary PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 148 Hungary PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 149 Hungary PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 150 Hungary PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 151 Hungary PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 152 Hungary PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 153 Hungary PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 154 Austria PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 155 Austria PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 156 Austria PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 157 Austria PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 158 Austria PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 159 Austria PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 160 Austria PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 161 Norway PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 162 Norway PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 163 Norway PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 164 Norway PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 165 Norway PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 166 Norway PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 167 Norway PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 168 Ireland PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 169 Ireland PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 170 Ireland PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 171 Ireland PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 172 Ireland PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 173 Ireland PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 174 Ireland PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 175 Belgium PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 176 Belgium PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 177 Belgium PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 178 Belgium PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 179 Belgium PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 180 Belgium PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 181 Belgium PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 182 Lithuania PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 183 Lithuania PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 184 Lithuania PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 185 Lithuania PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 186 Lithuania PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 187 Lithuania PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 188 Lithuania PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 189 rest of europe PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 190 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 191 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 192 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 193 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 194 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 195 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 196 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 197 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 198 Saudi atrabia PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 199 Saudi Arabia PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 200 Saudi Arabia PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 201 Saudi Arabia PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 202 Saudi Arabia PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 203 Saudi Arabia PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 204 Saudi Arabia PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 205 israel PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 206 israel PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 207 israel PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 208 israel PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 209 israel PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 210 israel PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 211 israel PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 212 egypt PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 213 egypt PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 214 egypt PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 215 egypt PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 216 egypt PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 217 egypt PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 218 egypt PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 219 UAE PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 220 UAE PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 221 UAE PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 222 UAE PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 223 UAE PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 224 uae PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 225 UAE PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

图片列表

FIGURE 1 Global PSYCHEDELIC DRUGS MARKET: SEGMENTATION

FIGURE 2 GLOBAL PSYCHEDELIC DRUGS MARKET : DATA TRIANGULATION

FIGURE 3 global Psychedelic drugs Market: DROC ANALYSIS

FIGURE 4 Global Psychedelic drugs market: Global VS REGIONAL MARKET ANALYSIS

FIGURE 5 Global Psychedelic drugs Market: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL Psychedelic drugs MARKET: MULTIVARIATE MODELLING

FIGURE 7 GLOBAL Psychedelic drugs MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 GLOBAL PSYCHEDELIC DRUGS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 GLOBAL psychedelic drugs Market: MARKET APPLICATION COVERAGE GRID

FIGURE 10 GLOBAL PSYCHEDELIC DRUGS MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 Global Psychedelic drugs market: SEGMENTATION

FIGURE 12 NORTH AMERICA is expected to DOMINATE THE GLOBAL Psychedelic drugs market GROWing WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 13 GROWING ACCEPTANCE OF PSYCHEDELIC DRUGS FOR TREATING DEPRESSION AND INCREASING PREVALENCE OF DEPRESSION AND MENTAL DISORDERS are DRIVing THE global Psychedelic drugs MARKET IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 14 SYNTHETIC SEGMENT is expected to account for the largest share of the global PSYCHEDELIC DRUGS MARKET in 2021 & 2028

FIGURE 15 North america is the fastest growing market FOR Psychedelic drugs MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF GLOBAL PSYCHEDELIC DRUGS MARKET

FIGURE 17 MENTAL ILLNESS AMONG THE U.S. ADULTS, IN 2018, BY DEMOGRAPHIC GROUP

FIGURE 18 MENTAL ILLNESS TREATMENT RATES AMONG THE U.S. ADULTS, IN 2018, BY DEMOGRAPHIC GROUP

FIGURE 19 MENTAL ILLNESS TREATMENT RATES AMONG THE U.S. ADULTS, IN 2018, BY GENDER

FIGURE 20 PREVALENCE OF MENTAL HEALTH DISORDERS BY DISORDER TYPE, IN WORLD, IN 2017

FIGURE 21 MAGIC MUSHROOMS PRICES FOR RESEARCHERS, IN THE U.S.

FIGURE 22 global psychedelic drugs market: BY source, 2020

FIGURE 23 global psychedelic drugs market: BY source, 2021-2028 (USD Million)

FIGURE 24 global psychedelic drugs market: BY source, CAGR (2021-2028)

FIGURE 25 global psychedelic drugs market: BY source, LIFELINE CURVE

FIGURE 26 global psychedelic drugs market: BY type, 2020

FIGURE 27 global psychedelic drugs market: BY type, 2021-2028 (USD Million)

FIGURE 28 global psychedelic drugs market: BY type, CAGR (2021-2028)

FIGURE 29 global psychedelic drugs market: BY type, LIFELINE CURVE

FIGURE 30 global psychedelic drugs market: BY drugs, 2020

FIGURE 31 global psychedelic drugs market: BY drugs, 2021-2028 (USD Million)

FIGURE 32 global psychedelic drugs market: BY drugs, CAGR (2021-2028)

FIGURE 33 global psychedelic drugs market: BY drugs, LIFELINE CURVE

FIGURE 34 global psychedelic drugs market: BY application, 2020

FIGURE 35 global psychedelic drugs market: BY application, 2021-2028 (USD Million)

FIGURE 36 global psychedelic drugs market: BY applicaiton, CAGR (2021-2028)

FIGURE 37 global psychedelic drugs market: BY application, LIFELINE CURVE

FIGURE 38 global psychedelic drug market: BY route of administraiton, 2020

FIGURE 39 global psychedelic drug market: BY route of administration, 2020-2028 (USD Million)

FIGURE 40 global psychedelic drug market: BY route of administration, CAGR (2020-2028)

FIGURE 41 global psychedelic drug market: BY route of administration, LIFELINE CURVE

FIGURE 42 global psychedelic drug market: BY end user, 2020

FIGURE 43 global psychedelic drug market: BY end user, 2020-2028 (USD Million)

FIGURE 44 global psychedelic drug market: BY end user, CAGR (2020-2028)

FIGURE 45 global psychedelic drug market: BY end user, LIFELINE CURVE

FIGURE 46 global psychedelic drugs market: BY distribution channel, 2020

FIGURE 47 global psychedelic drugs market: BY distribution channel, 2020-2028 (USD Million)

FIGURE 48 global psychedelic drugs market: BY distribution channel, CAGR (2020-2028)

FIGURE 49 global psychedelic drugs market: BY distribution channel, LIFELINE CURVE

FIGURE 50 GLOBAL Psychedelic Drugs MARKET: SNAPSHOT (2020)

FIGURE 51 GLOBAL Psychedelic Drugs MARKET: BY Region (2020)

FIGURE 52 GLOBAL Psychedelic Drugs MARKET: BY Region (2020 & 2028)

FIGURE 53 GLOBAL Psychedelic Drugs MARKET: BY Region (2020 & 2028)

FIGURE 54 GLOBAL Psychedelic Drugs MARKET: BY type (2021-2028)

FIGURE 55 NORTH AMERICA PSYCHEDELIC DRUGS MARKET: SNAPSHOT (2020)

FIGURE 56 NORTH AMERICA PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2020)

FIGURE 57 NORTH AMERICA PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 58 NORTH AMERICA PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 59 NORTH AMERICA PSYCHEDELIC DRUGS MARKET: BY SOURCE (2021-2028)

FIGURE 60 EUROPE PSYCHEDELIC DRUGS MARKET: SNAPSHOT (2020)

FIGURE 61 EUROPE PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2020)

FIGURE 62 EUROPE PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 63 EUROPE PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 64 EUROPE PSYCHEDELIC DRUGS MARKET: BY SOURCE (2021-2028)

FIGURE 65 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: SNAPSHOT (2020)

FIGURE 66 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2020)

FIGURE 67 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 68 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 69 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY SOURCE (2021-2028)

FIGURE 70 Global Psychedelic drugs market: company share 2020 (%)

FIGURE 71 north america Psychedelic drugs market: company share 2020 (%)

FIGURE 72 europe Psychedelic drugs market: company share 2020 (%)

FIGURE 73 Middle East AND Africa Psychedelic drugs market: company share 2020 (%)

查看详细信息 Right Arrow

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

Rising Support for Psychedelic Therapy & Worldwide Shift Towards Psychedelic Legalization and Decriminalization are the growth drivers of the psychedelic drugs market.
Source, type, drugs, application, route of administration, end-user, and distribution channel are the factors on which the psychedelic drugs market research is based.
The major companies in the psychedelic drugs market are Jazz Pharmaceuticals, Inc. (U.S.), Janssen Pharmaceuticals, Inc. (U.S.), Hikma Pharmaceuticals PLC (U.K.), Compass (U.S.), Verrian (Germany), Pfizer Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Avadel (Ireland), Celon Pharma SA (Poland), Cybin Corp. (Canada), GH Research (Ireland), Entheon Biomedical Corp (Canada), PharmaTher Holdings Ltd. (India), NRx Pharmaceuticals, Inc. (U.S.), and Usona Institute (U.S.).
The psychedelic drugs market size will be worth USD 7.35 billion by 2031.
The psychedelic drugs market growth rate will be 13.3% by 2031.

浏览相关页面

Banner